Safety Rates Drug Report: Ranibizumab Vitreous floaters adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: Ranibizumab Injury: Vitreous floaters Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 2 Number of Pages: 1

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
124358932	Ranibizumab	Vitreous floaters	ROCHE	0.00	F	0	20160928	FR
124672012	Ranibizumab	Vitreous floaters	ROCHE	68.00 YR	F	0	20160926	FR

|< 1/2 << Previous Page Page 1

Total Records: 2 Number of Pages: 1

Execution Time: 0.025118827819824 seconds (ucode:5111252). Developed by: James D. Barger